Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N2SR
|
||||
Former ID |
DNCL001905
|
||||
Drug Name |
Selexipag
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Actelion Pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H32N4O4S
|
||||
InChI |
InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)
|
||||
InChIKey |
QXWZQTURMXZVHJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Prostacyclin receptor | Target Info | Agonist | [531815] | |
Pathway Interaction Database | Thromboxane A2 receptor signaling | ||||
References | |||||
Ref 523009 | ClinicalTrials.gov (NCT01106014) Selexipag (ACT-293987) in Pulmonary Arterial Hypertension, GRIPHON Trial. U.S. National Institutes of Health. | ||||
Ref 542553 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7552). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.